Fortress Biotech (FBIO) Interest & Investment Income (2010 - 2026)
Fortress Biotech (FBIO) posted quarterly Interest & Investment Income of $637000.0 for Q4 2025, up 21.1% year-over-year from $526000.0 in Q4 2024, and down 13.45% quarter-over-quarter from $736000.0 in Q3 2025.
Powered by 
Analysis
Fortress Biotech (FBIO) Interest & Investment Income (2010 - 2026) Analysis & Trends
Fortress Biotech's Interest & Investment Income history runs 16 years deep, the most recent figure standing at $637000.0 for Q4 2025.
- In Q4 2025, Interest & Investment Income rose 21.1% year-over-year to $637000.0; the TTM figure through Dec 2025 stood at $2.5 million (down 7.35% YoY), while the FY2025 annual figure was $2.5 million, down 7.38% from the prior year.
- Interest & Investment Income for Q4 2025 stood at $637000.0, down from $736000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $1.0 million in Q1 2023, with the low at $132000.0 in Q3 2021.
- The 5-year median for Interest & Investment Income is $568000.0 (2023), against an average of $510950.0.
- The sharpest annual moves came in 2021 and 2023: Interest & Investment Income slumped 63.8% in 2021, then jumped 629.58% in 2023.
- Fortress Biotech's Interest & Investment Income stood at $144000.0 in 2021, then soared by 377.08% to $687000.0 in 2022, then gained by 2.91% to $707000.0 in 2023, then retreated by 25.6% to $526000.0 in 2024, then gained by 21.1% to $637000.0 in 2025.
- Business Quant data shows FBIO's Interest & Investment Income at $637000.0 in Q4 2025, $736000.0 in Q3 2025, and $622000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | 1.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.58 Mn |
| Dec 31, 2025 | 637,000.00 |
| Sep 30, 2025 | 736,000.00 |
| Jun 30, 2025 | 622,000.00 |
| Mar 31, 2025 | 490,000.00 |
| Dec 31, 2024 | 526,000.00 |
| Sep 30, 2024 | 589,000.00 |
| Jun 30, 2024 | 734,000.00 |
| Mar 31, 2024 | 833,000.00 |
| Dec 31, 2023 | 707,000.00 |
| Sep 30, 2023 | 547,000.00 |
| Jun 30, 2023 | 715,000.00 |
| Mar 31, 2023 | 1.04 Mn |
| Dec 31, 2022 | 687,000.00 |
| Sep 30, 2022 | 419,000.00 |
| Jun 30, 2022 | 150,000.00 |
| Mar 31, 2022 | 142,000.00 |
| Dec 31, 2021 | 144,000.00 |
| Sep 30, 2021 | 132,000.00 |
| Jun 30, 2021 | 146,000.00 |